First Time Loading...
N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 24.64 CNY -1.28%
Updated: May 21, 2024
Nanjing Vazyme Biotech Co Ltd
/
Cash Flow Statement
/
Cash from Financing Activities

Nanjing Vazyme Biotech Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanjing Vazyme Biotech Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
N
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Cash from Financing Activities
¥249.8m
CAGR 3-Years
-1%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Financing Activities
¥2.6B
CAGR 3-Years
-57%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Financing Activities
¥2.6B
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Financing Activities
-¥893.3m
CAGR 3-Years
N/A
CAGR 5-Years
-98%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Financing Activities
-¥4.6B
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
-50%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Financing Activities
-¥374.2m
CAGR 3-Years
-104%
CAGR 5-Years
-98%
CAGR 10-Years
N/A

See Also

What is Nanjing Vazyme Biotech Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
249.8m CNY

Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Cash from Financing Activities amounts to 249.8m CNY.

What is Nanjing Vazyme Biotech Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
50%

Over the last year, the Cash from Financing Activities growth was 216%. The average annual Cash from Financing Activities growth rates for Nanjing Vazyme Biotech Co Ltd have been -1% over the past three years , 50% over the past five years .

ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.